PE-22-28 Dosage Guide
Complete guide to PE-22-28 dosing protocols, administration methods, and safety considerations for research purposes.
NOT Medical Advice
The dosage and calculator information provided is for educational and research purposes only. Peptides are not approved by the FDA for human use. Individual responses vary significantly. Always consult with a qualified healthcare professional before making any decisions related to peptide research or use.
Dosage Overview
Dose per Injection
500 mcg – 2 mg
Frequency
Once per day
Route
subcutaneous
Cycle Length
1–2 weeks
Reconstitution
Vial Size
5 mg
BAC Water
2.0 ml
Concentration
2,500 mcg/ml
Detailed Dosage Information
Research protocols vary.
Intranasal dosing has been studied at various concentrations.
Optimal human dosing not established.
Administration Method
Intranasal administration preferred for CNS delivery. Research compound with limited human use data.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Concentration: 2.5 mg/ml
Volume to inject: 0.20 ml
Syringe units (U-100): 20.0 units
Pre-filled with PE-22-28 defaults. Adjust values as needed.
Side Effects to Monitor
Very limited human data. Primarily studied in animal models for safety and efficacy.
Safety Considerations & Risks
Highly experimental. Most data from animal studies. Long-term effects completely unknown.